- Home
- LPCN vs DUOT Comparison
LPCN vs DUOT Comparison
Compare LPCN & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- DUOT
- Stock Information
- Founded
- LPCN 1997
- DUOT 1990
- Country
- LPCN United States
- DUOT United States
- Employees
- LPCN N/A
- DUOT N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- DUOT Computer Software: Prepackaged Software
- Sector
- LPCN Health Care
- DUOT Technology
- Exchange
- LPCN Nasdaq
- DUOT Nasdaq
- Market Cap
- LPCN 36.8M
- DUOT 34.8M
- IPO Year
- LPCN N/A
- DUOT N/A
- Fundamental
- Price
- LPCN $4.87
- DUOT $5.70
- Analyst Decision
- LPCN Strong Buy
- DUOT Strong Buy
- Analyst Count
- LPCN 1
- DUOT 2
- Target Price
- LPCN $10.00
- DUOT $8.75
- AVG Volume (30 Days)
- LPCN 33.5K
- DUOT 114.1K
- Earning Date
- LPCN 11-07-2024
- DUOT 11-19-2024
- Dividend Yield
- LPCN N/A
- DUOT N/A
- EPS Growth
- LPCN N/A
- DUOT N/A
- EPS
- LPCN N/A
- DUOT N/A
- Revenue
- LPCN $7,922,926.00
- DUOT $7,346,014.00
- Revenue This Year
- LPCN N/A
- DUOT $33.94
- Revenue Next Year
- LPCN N/A
- DUOT $147.69
- P/E Ratio
- LPCN N/A
- DUOT N/A
- Revenue Growth
- LPCN N/A
- DUOT N/A
- 52 Week Low
- LPCN $2.44
- DUOT $1.94
- 52 Week High
- LPCN $11.79
- DUOT $6.44
- Technical
- Relative Strength Index (RSI)
- LPCN 47.54
- DUOT 63.28
- Support Level
- LPCN $4.68
- DUOT $4.35
- Resistance Level
- LPCN $5.28
- DUOT $4.89
- Average True Range (ATR)
- LPCN 0.36
- DUOT 0.53
- MACD
- LPCN -0.01
- DUOT -0.00
- Stochastic Oscillator
- LPCN 44.44
- DUOT 94.57
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.